The aim of the study is to study the genotypic characteristics of HIV-1 non-M circulating in the whole Cameroon and their genetic evolution.
HIV-1 is divided four distinct groups: M (major) which represents the pandemic strains while others groups O (outlier), N (non M, non O) and P are called non-M variants. Group O (HIV-O) is more divergent, endemic in Central Africa and Cameroon, where it represents about 1% of HIV infections. These variants are characterized by an important genetic divergence from pandemic HIV-1 group M (HIV-M), which impacts on the diagnosis, monitoring and treatment of infected patients. Although discovered in 1990, and emerged at the same time as HIV-M, no data of epidemiology, natural history and evolution of the genetic diversity of these variants is currently available. The few knowledge available to date come from sporadic cases, mainly through studies in Yaoundé. It is therefore essential to improve current knowledge on these variants and their consequences on infected patients. The aim of the study is to study the genotypic characteristics of HIV-1 non-M circulating in the whole Cameroon and their genetic evolution.
Study Type
OBSERVATIONAL
Enrollment
220
Blood samples will be collected in order to meet the objectives of this substudy and possibly for complementary research
Prevalence of non-M HIV-1 in Cameroon
Number of participants infected with non-M HIV-1 included compared to the total expected number of inclusions
Time frame: 1 day
Investigate the current molecular epidemiology of resistance in non-M HIV-1 variants in Cameroon
Proportion of non-M HIV-1 samples characterized genotypically among the samples collected from participants included in the project
Time frame: 1 Day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.